p300/CBP inhibition enhances the efficacy of programmed death-ligand 1 blockade treatment in prostate cancerJinghui Liu, Xiaoqi Liu, Yanquan Zhang et al.|Oncogene|2020Cited by 114
Targeting Plk1 Sensitizes Pancreatic Cancer to Immune Checkpoint TherapyZhuangzhuang Zhang, Xiaoqi Liu, Lijun Cheng et al.|Cancer Research|2022Cited by 68
mTORC1-Dependent Regulation of the CCL24-CCR3 Axis Controls Granuloma Formation and Maintenance in SarcoidosisXiongjian Rao, Xiaoqi Liu|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 0